Alto Neuroscience ANRO
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$1.14M (10 inflow days, 10 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 32.6% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 9.06% to 14.48% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Nicholas Smith | Individual/Insider | 2026/Q3 | +55,000 | 0.2% |
| BlackRock | Mutual Fund | 2026/Q3 | +605,097 | 6.8% |
| Invesco Capital Management LLC | Mutual Fund | 2026/Q3 | +339,492 | 0.8% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +301,276 | 4.2% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +260,095 | 2.4% |
| Morgan Stanley | Public Company | 2026/Q3 | +186,081 | 0.7% |
| Morgan Stanley Investment Management Inc. | Mutual Fund | 2026/Q3 | +186,081 | 0.7% |
| Geode Capital Management, LLC | Mutual Fund | 2026/Q3 | +154,060 | 2.1% |
| FMR | Mutual Fund | 2026/Q3 | +144,414 | 0.4% |
| Vanguard Portfolio Management, LLC | Mutual Fund | 2026/Q3 | +98,940 | 0.7% |
| Harvest Investment Services, LLC | Mutual Fund | 2026/Q3 | +63,991 | 0.2% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +56,133 | 0.1% |
| EcoR1 Capital, LLC | Hedge Fund | 2026/Q3 | +2,232,000 | 5.6% |
| BlackRock | Mutual Fund | 2026/Q3 | +1,454,821 | 5.4% |
| Adage Capital Management, L.P. | Hedge Fund | 2026/Q3 | +1,215,000 | 4.0% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 1 Oct 2026 | Nicholas Smith | CFO & President | Derivative Exercise and Retained | +55,000 | $2.32 | 79,060 |
| 29 Sep 2026 | Nicholas Smith | CFO & President | Derivative Exercise and Sale | -134,886 | $26.87 | 24,060 |
| 28 Sep 2026 | Nicholas Smith | CFO & President | Intent to Sell (Form 144) | -134,886 | $26.66 | – |
| 26 May 2026 | Andrew Miller | Director | Other Derivative Acquisition | +26,000 | $20.44 | 26,000 |
| 13 May 2026 | Amit Etkin | Founder, CEO & Chairman of the Board | Other Disposition | -400,000 | – | 833,949 |
| 11 May 2026 | Gwill York | Independent Director | Other Derivative Acquisition | +10,958 | $24.63 | 10,958 |
| 11 May 2026 | Andrew Dreyfus | Independent Director | Other Derivative Acquisition | +10,958 | $24.63 | 10,958 |
| 11 May 2026 | Husseini Manji | Non-Employee Independent Director | Other Derivative Acquisition | +10,958 | $24.63 | 10,958 |
| 11 May 2026 | Raymond Sanchez | Independent Director | Other Derivative Acquisition | +10,958 | $24.63 | 10,958 |
| 11 May 2026 | Christopher Cox | Lead Independent Director | Other Derivative Acquisition | +10,958 | $24.63 | 10,958 |
| 28 Feb 2026 | Nicholas Smith | CFO & President | Sale to Issuer | -2,806 | $19.69 | 24,060 |
| 28 Feb 2026 | Amit Etkin | Founder, CEO & Chairman of the Board | Sale to Issuer | -6,227 | $19.69 | 1,233,949 |
| 10 Feb 2026 | Nicholas Smith | CFO & President | Other Derivative Acquisition | +200,000 | $16.71 | 200,000 |
| 10 Feb 2026 | Amit Etkin | Founder, CEO & Chairman of the Board | Other Derivative Acquisition | +306,000 | $16.71 | 306,000 |
| 10 Feb 2026 | Michael Hanley | Chief Operating Officer | Other Derivative Acquisition | +131,000 | $16.71 | 131,000 |
| 10 Feb 2026 | Adam Savitz | Chief Medical Officer | Other Derivative Acquisition | +124,000 | $16.71 | 124,000 |
| 1 Jan 2026 | Gwill York | Independent Director | Other Derivative Acquisition | +5,243 | $16.59 | 5,243 |
| 1 Jan 2026 | Husseini Manji | Non-Employee Independent Director | Other Derivative Acquisition | +4,228 | $16.59 | 4,228 |
| 1 Jan 2026 | Raymond Sanchez | Independent Director | Other Derivative Acquisition | +3,806 | $16.59 | 3,806 |
| 1 Jan 2026 | Christopher Cox | Lead Independent Director | Other Derivative Acquisition | +7,189 | $16.59 | 7,189 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 5,682,860 | 14.5% | 10.5 |
| 15 Oct 2026 | 5,204,407 | 13.3% | 7.5 |
| 30 Sep 2026 | 4,660,269 | 11.9% | 6.5 |
| 15 Sep 2026 | 4,174,082 | 10.6% | 9.1 |
| 31 Aug 2026 | 3,836,359 | 9.8% | 8.1 |
| 14 Aug 2026 | 3,556,066 | 9.1% | 7.5 |
No comments yet — be the first to weigh in on ANRO.
Sign in to join the discussion.